Morgan Stanley expects the Chinese equity market to have mild upside through Q2 2027 and favors A-shares and thematic stock picking.

Overview

This is a Morgan Stanley midyear outlook on China equity strategy for 2026. The report’s core view is that Chinese equity indices have mild upside through Q2 2027, driven mainly by earnings improvement, modest RMB appreciation versus the USD, China’s rising importance in global advanced supply chains, and a temporary easing in China-US relations. However, because indices such as MSCI China are tilted toward large platform companies and apply a discount to A-share inclusion, index performance does not fully capture the strength of themes such as upstream assets, advanced manufacturing, semiconductors, energy, and materials.

Core views

The report maintains an equal-weight view on China within the EM/APxJ framework, but prefers to generate alpha through A-shares and thematic stock selection. The author believes pressure from downward earnings estimate revisions may ease over the next 6-12 months, supported by stronger exports, an AI/energy capex supercycle, anti-involution regulation that is bringing platform-company price competition damage toward a peak, and a stronger USDCNY outlook than before. On allocation, the report recommends A-shares over offshore markets, focusing on China’s best business model stocks, upstream global energy self-sufficiency supply-chain leaders, semiconductors and technology localization, and event-driven trades such as Hong Kong Stock Connect inclusions and deletions.

Analysis framework

The report uses a top-down China equity strategy framework that combines earnings, valuation, liquidity, FX, policy, geopolitics, and index composition to assess the market. Index targets are set under bull, base, and bear scenarios, and the target levels, EPS, and forward P/E for Hang Seng, HSCEI, MSCI China, and CSI300 are compared. Sector allocation is judged based on year-to-date performance, index-weight mismatches, the A-share inclusion discount, export share, supply-chain competitiveness, and theme durability.

Methodology notes

• Equity strategy frameworkMorgan Stanley China Equity Strategy Evaluation Framework

  multi-factor market assessment

  The report focuses on variables such as earnings revisions, FX, valuation, liquidity, policy, global macro conditions, and China-US relations, and argues that at least three of these factors need to improve before the market can be turned materially more positive.

• Index target settingBull / Base / Bear scenario targets

  scenario analysis

  The report sets Q2 2027 bull, base, and bear targets for the major Chinese equity indices, using different EPS growth, valuation multiples, and macro assumptions to gauge potential upside or downside.

• Index structure analysisMSCI China pro forma weight re-estimation

  index constituent and inclusion-factor adjustment

  By adding Entity List and NS-CMIC List stocks and assuming eligible A-share constituents are included at a 100% inclusion factor, the report estimates how MSCI China sector weights could change, showing that semiconductors, capital goods, technology hardware, and materials could see materially higher weights.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• A-shares

  Relative preference

  Strengths

  Higher concentration of companies in advanced upstream manufacturing, hard tech, and semiconductors; potential A-share IPOs such as YMTC, CXMT, and Unitree Technology could boost participation by domestic institutions and retail investors; state support improves downside cushioning.

  Weaknesses

  Still affected by domestic disinflation, weak consumer demand, and first-quarter earnings misses.

  Comparison

  More favored by the report than China offshore markets.

  Risks

  If earnings recovery is delayed, policy support falls short of expectations, or global risk appetite declines, the theme premium in A-shares may fade.

• China offshore equities / Hong Kong stocks

  Slight underweight but with event-driven opportunities

  Strengths

  Hong Kong Stock Connect inclusion, index inclusion, and ETF flows may provide temporary catalysts.

  Weaknesses

  Heavier weighting in large platform companies makes them more exposed to price competition, earnings downgrades, and liquidity uncertainty.

  Comparison

  The report recommends A-shares over offshore markets.

  Risks

  Hong Kong IPO lockup expiries, cooling southbound flows, USD liquidity, and delayed Fed cuts may increase volatility.

• MSCI China

  Equal weight at the index level

  Strengths

  Base case target of 91 implies about 12% upside; if disinflation breaks earlier and China-US relations improve, the bull case could offer larger upside.

  Weaknesses

  The index is overly tilted toward large platform companies, and the A-share inclusion discount leaves stronger sectors underrepresented.

  Comparison

  Compared with stock-picking and thematic portfolios, the report believes passive index exposure does not fully express the return opportunity.

  Risks

  In the bear case it could fall by about 26%, affected by disinflation, slower global growth, and China-US risks.

• Hang Seng / HSCEI

  Moderate upside

  Strengths

  Base case targets of 28,400 and 9,900, implying about 8% and 11% upside, respectively.

  Weaknesses

  Affected by Hong Kong market liquidity, IPO lockup expiries, and platform-company weighting.

  Comparison

  Upside is slightly lower than, or similar to, MSCI China and CSI300.

  Risks

  If southbound flows cool materially from 2025 highs or global liquidity tightens, valuation expansion will be limited.

• CSI300

  Mild upside supported by A-share preference

  Strengths

  Base case target of 5,400, implying about 11% upside; supported by A-share hard-tech and manufacturing themes.

  Weaknesses

  Macro reflation remains insufficient, and real estate and consumer drags persist.

  Comparison

  Its upside is broadly similar to HSCEI and MSCI China in the report’s China index targets.

  Risks

  If policy stays in cruise mode rather than stepping up, and earnings recovery disappoints, index elasticity will be limited.

• Upstream asset-heavy sectors: materials, industrials, energy

  Strong preference

  Strengths

  Less disrupted by the AI supercycle; supported by global energy self-sufficiency and renewed emphasis on efficiency; China’s supply-chain competitiveness is strong and export share has room to rise.

  Weaknesses

  More sensitive to global energy prices, external demand, and geopolitical developments.

  Comparison

  More favored by the report than large platforms, consumer, and real estate.

  Risks

  Global demand destruction, changes in the oil price path, or trade restrictions could affect earnings and valuation.

• Semiconductors and technology localization

  Key theme

  Strengths

  Supported by China-US tech competition, policy support, and the direction of the 15th Five-Year Plan; related names are more concentrated in A-shares.

  Weaknesses

  Valuations may already reflect high expectations, and the pace of technological breakthroughs and commercialization is uncertain.

  Comparison

  In pro forma index weights, semiconductor weight could be materially higher than the current MSCI China weight.

  Risks

  If AI/LLM capabilities or monetization underperform expectations, support for theme valuations may weaken.

Key data

• Hang Seng base case target28,400Q2 2027 target, implying about 8% upside versus the 2026-05-08 current level of 26,394.
• HSCEI base case target9,900Q2 2027 target, implying about 11% upside versus the current 8,889.
• MSCI China base case target91Q2 2027 target, implying about 12% upside versus the current 81; the bull/bear range is roughly +27% to -26%.
• CSI300 base case target5,400Q2 2027 target, implying about 11% upside versus the current 4,872.
• MSCI China 2026 earnings growth forecast7%Up from the prior 6% forecast, mainly supported by exports, FX, and the peaking of damage from platform-company price competition.
• MSCI China forward valuation assumption12.2xTarget 12-month forward P/E in the base case, slightly above the current roughly 11.9x, but below the prior 12.7x forecast.
• China real GDP forecast4.8% in 2026; 4.7% in 2027Morgan Stanley’s China economics team raised the 2026 real GDP forecast by 0.1 percentage point.
• China GDP deflator forecast0.5% in 2026Raised by 0.3 percentage point, but the report still believes reflation will be narrow, with consumer and real estate remaining drags.
• China's share of global exportsBase case roughly 1-2 percentage point increase by 2030The chart shows that under the base case, the share of global exports is expected to rise from about 15% to about 16.5%.
• YTD return of leading sectorsAbout 2%-30%Sectors such as energy, materials, advanced manufacturing, semiconductors, and healthcare have outperformed the index, but remain underrepresented in MSCI China.

Impact & implications

For investors, the implication is that China equities should not be represented solely by passive indices such as MSCI China. At the index level, the view remains mildly positive with an equal-weight stance, but structural opportunities are more concentrated in A-shares, upstream assets, advanced manufacturing, semiconductors, energy self-sufficiency, and technology localization. If disinflation turns earlier than expected, China-US relations continue to improve, and AI/semiconductor and large-model commercialization achieve breakthroughs, index-level upside could expand; conversely, if global growth deteriorates, an energy shock intensifies, or China-US tensions recur, market risk premia and earnings expectations could come under renewed pressure.

Risks

• The Q1 earnings season may still bring another round of earnings downgrades, and improvements in platform-company price competition may not become more visible until after second-quarter results.
• The July lockup expiry for Hong Kong IPO shares may offset some of the positive inflows from index inclusions, ETF flows, and southbound flows.
• If expectations for Fed cuts disappear or turn into hikes, liquidity may tighten further and limit valuation upside.
• High global energy prices and uncertainty in the Middle East may affect the global growth and inflation path.
• If the domestic disinflation environment fails to reach a clear turning point for too long, consumer and real estate drags will limit broad index upside.
• If China-US relations deteriorate again or technology restrictions escalate, China equity risk premia may rise.
• Global macro growth paths are highly divergent; if the US or the global economy enters a recession scenario, China’s exports and earnings growth will come under pressure.

What to watch

• Whether platform-company earnings in Q2 2026 and beyond show signs that price competition damage has peaked.
• Whether China’s disinflation cycle shows a clear break earlier, especially in consumer demand, employment, and real estate.
• Whether the May China-US summit and subsequent trade, technology, and geopolitical relations bring sustained easing.
• Whether the Fed’s rate-cut path continues to be delayed and how USD liquidity affects Hong Kong and offshore Chinese equity valuations.
• Whether southbound funds continue to see net inflows and whether the scale remains materially below the 2025 highs.
• Funding-flow changes driven by Hong Kong Stock Connect, Hang Seng Tech, and Hang Seng index inclusions and deletions.
• Whether potential large technology IPOs in A-shares increase participation by domestic investors.
• Whether AI, semiconductors, biotech, and advanced manufacturing show verifiable technological breakthroughs and global share expansion.